Coller Capital's latest findings are in line with PEI's LP Perspectives 2023 Study in which 22% of respondents said they intend to sell stakes only over the next year.
The former head of alternative investments at healthcare provider Kaiser Permanente is expected to focus on growth equity, VC and secondaries activity.
Pension giant is reviving plans that were scrapped last year, head of the strategic alternative investments Jeryang Lee told delegates at the PDI: Seoul Forum.
The situation is an example of the challenges of completing LP portfolio sales in today’s market, with a widening gap between buyer and seller pricing expectations.
The $59.4bn Swedish insurer doesn't want to support a phenomenon where a 'big chunk of money' is left on the table for LPs that is then handed over to another party.
Stephen Whatmore, head of global private capital at the $69bn Australian investor, discloses how it decides whether to roll or sell in GP-led processes.